Are you making a positive impact with your prostate cancer patients?

Connect with Isoray during #ASTRO17

The ASTRO Annual Meeting is the world’s most important meeting for the radiation oncology community, with more than 11,000 attendees each year. This year’s edition takes place September 24- 27 at the San Diego Convention Center- Isoray looks forward to attending and networking with leaders in radiation oncology as we communicate the value of brachytherapy in improving patient outcomes and quality of life.

Connect with the Isoray team at ASTRO 2017 by visiting booth #1532. To schedule a meeting time in advance, contact Neli Valdez at nvaldez@isoray.com.

Presentations featuring Cesium-131 by Isoray


Long-Term PSA Outcomes in a Single Institution, Prospective Randomized 131Cs / 125I Permanent Prostate Brachytherapy Trial by Brian Moran, MD


1:15 p.m. – 2:45 p.m. in Poster Hall

 

ASTRO 2017 Hosted Programs

For ASTRO 2017, we invite you to join us for at least one of our dinner programs on how Cesium-131 can positively impact your patients and your practice.

A New Targeted Approach using Cesium-131 Permanent Interstitial Brachytherapy:
Techniques every Gynecological Radiation Oncologist Should Know

Sunday, September 24th at 6:30 pm
SEASONS 52, 789 W Harbor Dr, San Diego, CA  92101

A discussion and presentation over dinner led by industry expert and pioneer Jonathan Feddock, MD. He will discuss his experience with using Cesium-131 brachytherapy for the treatment of recurrent gynecological cancers.  


Please RSVP by Thursday, September 21st to William Gallien at wgallien@isoray.com

Are you making a positive impact with your prostate cancer patients?

Monday, September 25th at 6:30 pm
SEASONS 52, 789 W Harbor Dr, San Diego, CA  92101

A discussion over dinner led by industry experts Brad Prestidge, MD and Brian Moran, MD. Together, they will discuss brachytherapy in the era of value based care and how Cesium-131 is improving patient outcomes and quality of life.

Please RSVP by Thursday, September 21st to Neli Valdez at nvaldez@isoray.com

Our Patient’s Stories

Connect with Isoray at ASTRO 2017

Connect with the Isoray team at ASTRO 2017 to learn about Cesium brachytherapy’s ability to improve patient outcomes while reducing costs by visiting booth #1532. To schedule a meeting time in advance, contact Isoray’s Bill Gallien via email: wgallien@isoray.com

Physician Spotlights

Leading Urologist Breaks Barriers in Successfully Treating Prostate Cancer with Brachytherapy
Pioneer in Prostate Cancer Treatment Leads Data-Driven Approach to Conquer Disease
Still Going Strong After 15,000 Cases: Chicago Prostate Cancer Center Focuses on What is Best for the Patient

 

“I am a huge believer in Brachytherapy. It is the best option in treating prostate cancer.”

Dr. Steven Kurtzman, MD

Director of Prostate Radiation, El Camino Hospital’s Center of Advanced Radiation Therapy

“Perminent Interstitial Brachytherapy with Cesium-131 should atleast be considered for any woman presented with a local recurrence of gynecological cancer.”

Dr. Jonathan Feddock, MD

Assistant Professor of Radiation Medicine, UK Healthcare